The DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.
Weight Gain and Metabolic Risks Associated with Antipsychotic Medications in Children and Adolescents
Abstract
BACKGROUND: Antipsychotic-related weight gain and metabolic adverse effects have become a major focus, especially in youth. METHODS: Review of randomized, cohort, and pharmacoepidemiologic studies of antipsychotic-related weight gain and metabolic adverse effects and of interventions for their reduction in youth. RESULTS: Across 34 published head-to-head and placebo-controlled studies in youth with psychotic and bipolar disorders, weight gain ranged from 3.8 to 16.2 kg with olanzapine (n=353), 0.9-9.5 kg with clozapine (n=97), 1.9-7.2 kg with risperidone (n=571), 2.3-6.1 kg with quetiapine (n=133), and 0-4.4 kg with aripiprazole (n=451). In 24 placebo-controlled trials, the numbers-needed-to-harm for weight gain ≥7% in youth with bipolar disorder and schizophrenia were 39 (confidence interval [CI]: -1 to +6, not significant) for aripiprazole, 36 (CI: -1 to +7, not significant) for ziprasidone, 9 (CI: 7-14) for quetiapine, 6 (CI: 5-8) for risperidone, and 3 (CI: 3-4) for olanzapine. Data in youth with autism and disruptive behavior disorders, available only for some antipsychotics, suggest greater weight gain, possibly due to less prior antipsychotic exposure. Three-month results from a large cohort study in antipsychotic-naïve youth indicated that metabolic effects differ among second-generation antipsychotics, despite significant weight gain with all studied agents, suggesting additional, weight-independent effects. Further, pharmacoepidemiologic work indicates that antipsychotic polypharmacy increases the risk for obesity (odds ratio [OR]: 2.28 [CI: 1.49-3.65]) or any cardiovascular, cerebrovascular, or hypertensive adverse event (OR: 1.72 [CI: 1.10-2.69]). However, despite marked weight gain and its greater impact on youth, monitoring rates are low and studies of pharmacologic and behavioral interventions are extremely limited. CONCLUSIONS: More research is needed to develop strategies to minimize antipsychotic-related weight gain and metabolic effects in youth and to discover treatments with lower risk potential.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051688 · Cited by 5,892
Obesity and the Metabolic Syndrome in Children and Adolescents
Weiss, R., Dziura, J., Burgert, T. S., Tamborlane, W. V., Taksali, S. E., Yeckel, C. W., Allen, K., Lopes, M., Savoye, M., Morrison, J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031049 · Cited by 3,459
Prevalence of High Body Mass Index in US Children and Adolescents, 2007-2008
Ogden, C. L. (2010) · JAMA · doi:10.1001/jama.2009.2012 · Cited by 3,200
Antipsychotic-induced weight gain: a comprehensive research synthesis
Allison, D. B., Mentore, J. L., Heo, M., Chandler, L. P., Cappelleri, J. C., Infante, M. C., & Weiden, P. J. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.11.1686 · Cited by 2,382
Second-Generation (Atypical) Antipsychotics and Metabolic Effects: A Comprehensive Literature Review
Newcomer, J. W. (2005) · CNS Drugs · doi:10.2165/00023210-200519001-00001 · Cited by 1,340
Increased incidence of non-insulin-dependent diabetes mellitus among adolescents
Pinhas-Hamiel, O., Dolan, L. M., Daniels, S. R., Standiford, D., Khoury, P. R., & Zeitler, P. (1996) · The Journal of Pediatrics · doi:10.1016/s0022-3476(96)80124-7 · Cited by 1,172
Kahn, R. S., Fleischhacker, W. W., Boter, H., Davidson, M., Vergouwe, Y., Keet, I. P., Gheorghe, M. D., Rybakowski, J. K., Galderisi, S., Libiger, J., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60486-9 · Cited by 1,088
Correll, C. U. (2009) · JAMA · doi:10.1001/jama.2009.1549 · Cited by 1,050
Self-citationDe Hert, M., Dekker, J. M., Wood, D., Kahl, K. G., Holt, R. I. G., & Möller, H.-J. (2009) · European Psychiatry · doi:10.1016/j.eurpsy.2009.01.005 · Cited by 951 · cited 1×
“…glucose and lipid abnormalities, and metabolic syndrome, particularly, of second-generation antipsychotics (SGAs), have become a clinical, research, and regulatory focus (Allison et al. 1999; American Diabetes Association et al. 2004; Lieberman et al. 2005; Kahn et al. 2008; De Hert et al. 2009).”
Davis, P. H., Dawson, J. D., Riley, W. A., & Lauer, R. M. (2001) · Circulation · doi:10.1161/hc4601.099486 · Cited by 884
Kroeze, W. K., Hufeisen, S. J., Popadak, B. A., Renock, S. M., Steinberg, S., Ernsberger, P., Jayathilake, K., Meltzer, H. Y., & Roth, B. L. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300027 · Cited by 801
Aripiprazole in the Treatment of Irritability in Children and Adolescents With Autistic Disorder
Owen, R., Sikich, L., Marcus, R. N., Corey-Lisle, P., Manos, G., McQuade, R. D., Carson, W. H., & Findling, R. L. (2009) · Pediatrics · doi:10.1542/peds.2008-3782 · Cited by 613
National Trends in the Outpatient Treatment of Children and Adolescents With Antipsychotic Drugs
Olfson, M., Blanco, C., Liu, L., Moreno, C., & Laje, G. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.6.679 · Cited by 591
Marcus, R. N., Owen, R., Kamen, L., Manos, G., McQuade, R. D., Carson, W. H., & Aman, M. G. (2009) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e3181b76658 · Cited by 566
Shea, S., Turgay, A., Carroll, A., Schulz, M., Orlik, H., Smith, I., & Dunbar, F. (2004) · Pediatrics · doi:10.1542/peds.2003-0264-f · Cited by 566
Sikich, L., Frazier, J. A., McClellan, J., Findling, R. L., Vitiello, B., Ritz, L., Ambler, D., Puglia, M., Maloney, A. E., Michael, E., et al. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08050756 · Cited by 478
Aman, M. G., De Smedt, G., Derivan, A., Lyons, B., Findling, R. L., & Risperidone Disruptive Behavior Study Group (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.8.1337 · Cited by 475
Obesity in Children and Adolescents
Cali, A. M. G., & Caprio, S. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1363 · Cited by 451
Projecting the Future Diabetes Population Size and Related Costs for the U.S.
Huang, E. S., Basu, A., O'Grady, M., & Capretta, J. C. (2009) · Diabetes Care · doi:10.2337/dc09-0459 · Cited by 414
Childhood-Onset Schizophrenia: A Double-blind Clozapine-Haloperidol Comparison
Kumra, S. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830120020005 · Cited by 410
Endocrine and Metabolic Adverse Effects of Psychotropic Medications in Children and Adolescents
CORRELL, C. U., & CARLSON, H. E. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000220851.94392.30 · Cited by 403
Self-citationKim, S. F., Huang, A. S., Snowman, A. M., Teuscher, C., & Snyder, S. H. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611417104 · Cited by 394
(2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0219 · Cited by 383
Obesity: Genetic, molecular, and environmental aspects
Barness, L. A., Opitz, J. M., & Gilbert‐Barness, E. (2007) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.32035 · Cited by 373
A placebo-controlled trial of risperidone in Tourette syndrome
Scahill, L., Leckman, J. F., Schultz, R. T., Katsovich, L., & Peterson, B. S. (2003) · Neurology · doi:10.1212/01.wnl.0000055434.39968.67 · Cited by 362
De Hert, M., Dobbelaere, M., Sheridan, E. M., Cohen, D., & Correll, C. U. (2011) · European Psychiatry · doi:10.1016/j.eurpsy.2010.09.011 · Cited by 362
Self-citationMaayan, L., Hoogendoorn, C., Sweat, V., & Convit, A. (2011) · Obesity · doi:10.1038/oby.2011.15 · Cited by 345
Self-citationZiprasidone Treatment of Children and Adolescents With Tourette's Syndrome: A Pilot Study
SALLEE, F. R., KURLAN, R., GOETZ, C. G., SINGER, H., SCAHILL, L., LAW, G., DITTMAN, V. M., & CHAPPELL, P. B. (2000) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200003000-00010 · Cited by 341
Effects of Risperidone on Conduct and Disruptive Behavior Disorders in Children With Subaverage IQs
SNYDER, R., TURGAY, A., AMAN, M., BINDER, C., FISMAN, S., & CARROLL, A. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200209000-00002 · Cited by 335
Álvarez-Jiménez, M., Hetrick, S. E., González-Blanch, C., Gleeson, J. F., & McGorry, P. D. (2008) · British Journal of Psychiatry · doi:10.1192/bjp.bp.107.042853 · Cited by 317
Olanzapine Versus Placebo in the Treatment of Adolescents With Bipolar Mania
Tohen, M., Kryzhanovskaya, L., Carlson, G., DelBello, M., Wozniak, J., Kowatch, R., Wagner, K., Findling, R., Lin, D., Robertson-Plouch, C., et al. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06111932 · Cited by 315
A Double-Blind Pilot Study of Risperidone in the Treatment of Conduct Disorder
FINDLING, R. L., McNAMARA, N. K., BRANICKY, L. A., SCHLUCHTER, M. D., LEMON, E., & BLUMER, J. L. (2000) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200004000-00021 · Cited by 309
Sikich, L., Hamer, R. M., Bashford, R. A., Sheitman, B. B., & Lieberman, J. A. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300327 · Cited by 308
Antipsychotic drugs and obesity
Correll, C. U., Lencz, T., & Malhotra, A. K. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.10.010 · Cited by 307
Self-citationAttention-Deficit/Hyperactivity Disorder (ADHD) and Obesity: A Systematic Review of the Literature
Cortese, S., Angriman, M., Maffeis, C., Isnard, P., Konofal, E., Lecendreux, M., Purper-Ouakil, D., Vincenzi, B., Bernardina, B. D., & Mouren, M.-C. (2008) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408390701540124 · Cited by 274
Findling, R. L., Robb, A., Nyilas, M., Forbes, R. A., Jin, N., Ivanova, S., Marcus, R., McQuade, R. D., Iwamoto, T., & Carson, W. H. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07061035 · Cited by 271
Klein, D. J., Cottingham, E. M., Sorter, M., Barton, B. A., & Morrison, J. A. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.12.2072 · Cited by 271
Correll, C. U., Sheridan, E. M., & DelBello, M. P. (2010) · Bipolar Disorders · doi:10.1111/j.1399-5618.2010.00798.x · Cited by 255
Self-citationAntipsychotic Use in Children and Adolescents: Minimizing Adverse Effects to Maximize Outcomes
CORRELL, C. U. (2008) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e31815b5cb1 · Cited by 254
Self-citationArterial Stiffness and Stroke in Hypertension: Therapeutic Implications for Stroke Prevention
Laurent, S., & Boutouyrie, P. (2005) · CNS Drugs · doi:10.2165/00023210-200519010-00001 · Cited by 236
Buitelaar, J. K., van der Gaag, R. J., Cohen-Kettenis, P., & Melman, C. T. M. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n0405 · Cited by 236
Elterman, R. D., Glauser, T. A., Wyllie, E., Reife, R., Wu, S.-C., Pledger, G., & the Topiramate YP Study Group (1999) · Neurology · doi:10.1212/wnl.52.7.1338 · Cited by 235
Past and Present Progress in the Pharmacologic Treatment of Schizophrenia
Kane, J. M., & Correll, C. U. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10r06264yel · Cited by 232
Self-citationHaas, M., DelBello, M. P., Pandina, G., Kushner, S., Van Hove, I., Augustyns, I., Quiroz, J., & Kusumakar, V. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00750.x · Cited by 231
Maayan, L., Vakhrusheva, J., & Correll, C. U. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.21 · Cited by 230
Self-citationChildhood-Onset Schizophrenia: A Double-Blind, Randomized Clozapine-Olanzapine Comparison
Shaw, P., Sporn, A., Gogtay, N., Overman, G. P., Greenstein, D., Gochman, P., Tossell, J. W., Lenane, M., & Rapoport, J. L. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.7.721 · Cited by 225
Findling, R. L., Nyilas, M., Forbes, R. A., McQuade, R. D., Jin, N., Iwamoto, T., Ivanova, S., Carson, W. H., & Chang, K. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05164yel · Cited by 224
Kumra, S., Kranzler, H., Gerbino-Rosen, G., Kester, H. M., DeThomas, C., Kafantaris, V., Correll, C. U., & Kane, J. M. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.04.043 · Cited by 223
Self-citationTime trends in schizophrenia mortality in Stockholm county, Sweden: cohort study
Osby, U. (2000) · BMJ · doi:10.1136/bmj.321.7259.483 · Cited by 220
Hollander, E., Wasserman, S., Swanson, E. N., Chaplin, W., Schapiro, M. L., Zagursky, K., & Novotny, S. (2006) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2006.16.541 · Cited by 220
Trends in Antipsychotic Drug Use by Very Young, Privately Insured Children
Olfson, M., Crystal, S., Huang, C., & Gerhard, T. (2010) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2009.09.003 · Cited by 215
Risperidone in Children With Autism: Randomized, Placebo-Controlled, Double-Blind Study
Nagaraj, R., Singhi, P., & Malhi, P. (2006) · Journal of Child Neurology · doi:10.1177/08830738060210060801 · Cited by 214
Urbina, E. M., Kimball, T. R., McCoy, C. E., Khoury, P. R., Daniels, S. R., & Dolan, L. M. (2009) · Circulation · doi:10.1161/circulationaha.108.830380 · Cited by 211
Fraguas, D., Correll, C. U., Merchán-Naranjo, J., Rapado-Castro, M., Parellada, M., Moreno, C., & Arango, C. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2010.07.002 · Cited by 209
Self-citationNielsen, J., Skadhede, S., & Correll, C. U. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.78 · Cited by 207
Self-citationMorrato, E. H., Druss, B., Hartung, D. M., Valuck, R. J., Allen, R., Campagna, E., & Newcomer, J. W. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.179 · Cited by 199
Chang, J. S., Ahn, Y. M., Park, H. J., Lee, K. Y., Kim, S. H., Kang, U. G., & Kim, Y. S. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0505 · Cited by 192
Kumra, S., Oberstar, J. V., Sikich, L., Findling, R. L., McClellan, J. M., Vinogradov, S., & Charles Schulz, S. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm109 · Cited by 186
Correll, C. U., Penzner, J. B., Parikh, U. H., Mughal, T., Javed, T., Carbon, M., & Malhotra, A. K. (2006) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2005.08.007 · Cited by 184
Self-citationMcIntyre, R. S., & Jerrell, J. M. (2008) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.162.10.929 · Cited by 178
Luby, J., Mrakotsky, C., Stalets, M. M., Belden, A., Heffelfinger, A., Williams, M., & Spitznagel, E. (2006) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2006.16.575 · Cited by 177
DelBello, M. P., Chang, K., Welge, J. A., Adler, C. M., Rana, M., Howe, M., Bryan, H., Vogel, D., Sampang, S., Delgado, S. V., et al. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00728.x · Cited by 173
Acute and Long-Term Safety and Tolerability of Risperidone in Children with Autism
Aman, M. G., Arnold, M. D., McDougle, C. J., Vitiello, B., Scahill, L., Davies, M., McCracken, J. T., Tierney, E., Nash, P. L., Posey, D. J., et al. (2005) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2005.15.869 · Cited by 170
Preliminary evidence for brain complications in obese adolescents with type 2 diabetes mellitus
Yau, P. L., Javier, D. C., Ryan, C. M., Tsui, W. H., Ardekani, B. A., Ten, S., & Convit, A. (2010) · Diabetologia · doi:10.1007/s00125-010-1857-y · Cited by 168
Kryzhanovskaya, L., Schulz, S. C., Mcdougle, C., Frazier, J., Dittmann, R., Robertson-Plouch, C., Bauer, T., Xu, W., Wang, W., Carlson, J., et al. (2009) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e3181900404 · Cited by 168
Metabolic complications of obesity in childhood and adolescence: more than just diabetes
Nathan, B. M., & Moran, A. (2008) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e3282f43d19 · Cited by 166
JENSEN, P. S., YOUNGSTROM, E. A., STEINER, H., FINDLING, R. L., MEYER, R. E., MALONE, R. P., CARLSON, G. A., COCCARO, E. F., AMAN, M. G., BLAIR, J., et al. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e31802f1454 · Cited by 159
Metabolic Screening in Children Receiving Antipsychotic Drug Treatment
Morrato, E. H., Nicol, G. E., Maahs, D. M., Druss, B. G., Hartung, D. M., Valuck, R. J., Campagna, E. J., & Newcomer, J. W. (2010) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpediatrics.2010.48 · Cited by 150
Haas, M., Unis, A. S., Armenteros, J. L., Copenhaver, M. D., Quiroz, J. A., & Kushner, S. F. (2009) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2008.0144 · Cited by 148
Lewis, D. W., Winner, P. K., Saper, J. R., Ness, S. L., Polverejan, E., Wang, S., Kurland, C. L., Nye, J. S., Yuen, E., Eerdekens, M., et al. (2009) · PEDIATRICS · doi:10.1542/peds.2008-0642 · Cited by 148
A Comparison of Risperidone-Induced Weight Gain Across the Age Span
Safer, D. J. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000130558.86125.5b · Cited by 146
van Bellinghen, M., & Troch, C. (2001) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/104454601750143348 · Cited by 138
Reliability of 4 Outcome Measures in Pediatric Spinal Muscular Atrophy
Iannaccone, S. T. (2003) · Archives of Neurology · doi:10.1001/archneur.60.8.1130 · Cited by 134
Management of antipsychotic-related weight gain
Maayan, L. A., & Correll, C. U. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.85 · Cited by 133
Self-citationHellings, J. A., Zarcone, J. R., Crandall, K., Wallace, D., & Schroeder, S. R. (2001) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/10445460152595559 · Cited by 132
The prevalence of the metabolic syndrome and type 2 diabetes mellitus in children and adolescents
Molnár, D. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802811 · Cited by 131
Developments in Pediatric Psychopharmacology
Correll, C. U., Kratochvil, C. J., & March, J. S. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.11r07064 · Cited by 130
Self-citationTramontina, S., Zeni, C., Ketzer, C. R., Pheula, G. F., Narvaez, J. C. D. M., & Rohde, L. A. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04726 · Cited by 115
Weight gain in antipsychotic-naive patients: a review and meta-analysis
Tarricone, I., Gozzi, B. F., Serretti, A., Grieco, D., & Berardi, D. (2009) · Psychological Medicine · doi:10.1017/s0033291709990407 · Cited by 114
Armenteros, J. L., Lewis, J. E., & Davalos, M. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e3180323354 · Cited by 112
The Role of Psychosocial Interventions in Bipolar II Disorder: What Do We Know?
Swartz, H. A. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.0508e15 · Cited by 107
Narula, P. K., Rehan, H. S., Unni, K. E. S., & Gupta, N. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.02.001 · Cited by 105
DelBello, M. P., Adler, C. M., Whitsel, R. M., Stanford, K. E., & Strakowski, S. M. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0520 · Cited by 103
Haas, M., Eerdekens, M., Kushner, S. F., Singer, J., Augustyns, I., Quiroz, J. A., Pandina, G., & Kusumakar, V. (2009) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.107.046177 · Cited by 103
Findling, R. L., Johnson, J. L., McClellan, J., Frazier, J. A., Vitiello, B., Hamer, R. M., Lieberman, J. A., Ritz, L., McNamara, N. K., Lingler, J., et al. (2010) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2010.03.013 · Cited by 101
Fraguas, D., Merchán‐Naranjo, J., Laita, P., Parellada, M., Moreno, D. M., Ruíz-Sancho, A., Cifuentes, A., Giráldez, M., & Arango, C. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0717 · Cited by 101
Adverse events in children and adolescents treated with antipsychotic medications
Jerrell, J. M., & McIntyre, R. S. (2008) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.932 · Cited by 80
Olanzapine compared to quetiapine in adolescents with a first psychotic episode
Arango, C., Robles, O., Parellada, M., Fraguas, D., Ruíz-Sancho, A., Medina, Ó., Zabala, A., Bombín, I., & Moreno, D. M. (2009) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-009-0749-5 · Cited by 78
Wozniak, J. R., Mick, E. O., Waxmonsky, J. G., Kotarski, M., Hantsoo, L. V., & Biederman, J. (2009) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2009.0042 · Cited by 77
DelBello, M. P., Versavel, M., Ice, K. S., Keller, D., & Miceli, J. J. (2008) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2008.008 · Cited by 76
Arman, S., Sadramely, M. R., Nadi, M., & Koleini, N. (2008) · Saudi Medical Journal · doi:10.15537/1658-3175.4426 · Cited by 75
Castro‐Fornieles, J., Parellada, M., Soutullo, C. A., Baeza, I., González-Pinto, A. M., Graell, M., Payá, B., Moreno, D. M., de la Serna, E., & Arango, C. (2007) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2007.0138 · Cited by 69
Preliminary Findings Regarding Overweight and Obesity in Pediatric Bipolar Disorder
Goldstein, B. I., Birmaher, B. B., Axelson, D., Goldstein, T. R., Esposito-Smythers, C. L., Strober, M. A., Hunt, J., Leonard, H., Gill, M. K., Iyengar, S., et al. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n1215 · Cited by 69
Fleischhaker, C., Heiser, P., Hennighausen, K., Herpertz‐Dahlmann, B., Holtkamp, K., Mehler‐Wex, C., Rauh, R., Remschmidt, H., Schulz, E., & Warnke, A. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-008-0105-9 · Cited by 62
Weight gain associated with clozapine, olanzapine and risperidone in children and adolescents
Fleischhaker, C., Heiser, P., Hennighausen, K., Herpertz‐Dahlmann, B., Holtkamp, K., Mehler‐Wex, C., Rauh, R., Remschmidt, H., Schulz, E., & Warnke, A. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0602-7 · Cited by 59
Swadi, H. S., Craig, B. J., Pirwani, N. Z., Black, V., Buchan, J. C., & Bobier, C. (2009) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e3283320511 · Cited by 54
Jensen, J. B., Kumra, S., Leitten, W., Oberstar, J. V., Anjum, A., White, T. J. H., Wozniak, J. R., Lee, S. S., & Schulz, S. C. (2008) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2007.0123 · Cited by 53
The Safety of Olanzapine in Adolescents With Schizophrenia or Bipolar I Disorder
Kryzhanovskaya, L. A., Robertson-Plouch, C. K., Xu, W., Carlson, J. L., Merida, K. M., & Dittmann, R. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m03538 · Cited by 43
Morrato, E. H., Cuffel, B. J., Newcomer, J. W., Lombardo, I., Kamat, S., & Barron, J. O. (2009) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31819294cb · Cited by 40
QT Interval Duration and Dispersion in Children and Adolescents Treated With Ziprasidone
Correll, C. U., Lops, J. D., Figen, V., Malhotra, A. K., Kane, J. M., & Manu, P. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10m05990yel · Cited by 29
Self-citationCorrell, C. U. (2009) · Evidence-Based Mental Health · doi:10.1136/ebmh.12.3.93 · Cited by 18
Self-citationBody mass index (BMI) in newly admitted child and adolescent psychiatric inpatients
Vieweg, W. V. R., Kuhnley, L. J., Kuhnley, E. J., Anum, E. A., Sood, B., Pandurangi, A. K., & Silverman, J. J. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.01.001 · Cited by 14
Feeding our children to death: the tragedy of childhood obesity in America.
Freeman-Fobbs, P. (2003) · PubMed · Cited by 12
Adverse Events Associated With Psychotropic Treatment in African American Children and Adolescents
Jerrell, J. M. (2010) · Journal of the National Medical Association · doi:10.1016/s0027-9684(15)30572-1 · Cited by 10
Findling, R. L., Çavuş, I., Pappadolulos, E., Backinsky, M., Schwartz, J. H., & Vanderburg, D. G. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.02.808 · Cited by 9
Li, S., Chen, W., Srinivasan, S. R., Bond, M. G., Tang, R., Urbina, E. M., & Berenson, G. S. (2003) · JAMA · doi:10.1001/jama.290.17.2271 · Cited by 8
Research works printed but not linked: 13
- Arman S, 2008, Saudi Med J, 29, 1130
- Chang KD, 2008, J Clin Psychiatry, 69, 4
- Colton CW, 2006, Prev Chronic Dis, 3, A42
- De Hert M, 2011, Nat Rev Endocrinol
- DelBello M, 2007, Presented at 46th Annual Meeting of the American College of Neuropsychopharmacology
- DelBello M, 2008, Presented at 63rd Annual Meeting of the Society of Biological Psychiatry
- Findling R, 2008, Presented at 55th Annual Meeting of the American Academy of Child and Adolescent Psychiatry
- Findling RL, 2010, J Am Acad Child Adolesc Psychiatry, 49, 583
- Findling RL, 2008, Presented at 55th Annual Meeting of the American Academy of Child and Adolescent Psychiatry
- Freeman-Fobbs P, 2003, J Natl Med Assoc, 95, 119
- Maayan L, 2010, Presented at New Clinical Drug Evaluation Unit 50th Anniversary Meeting
- McDougle CJ, 2008, J Clin Psychiatry, 69, 15
- 10.1034/j.1399-5448.2000.010106.x · doi:10.1034/j.1399-5448.2000.010106.x
Cited by
Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline
Apovian, C. M., Aronne, L. J., Bessesen, D. H., McDonnell, M. E., Murad, M. H., Pagotto, U., Ryan, D. H., & Still, C. D. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3415 · Cited by 1,347
Correll, C. U., Detraux, J., De Lepeleire, J., & De Hert, M. (2015) · World Psychiatry · doi:10.1002/wps.20204 · Cited by 820
Self-citationDevelopmental timing and critical windows for the treatment of psychiatric disorders
Marín, O. (2016) · Nature Medicine · doi:10.1038/nm.4225 · Cited by 374
Mitchell, A. J., Vancampfort, D., De Herdt, A., Yu, W., & De Hert, M. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs082 · Cited by 327
Cooper, S. J., Reynolds, G. P., order):, W. E. C.-A. (. A., Barnes, T., England, E., Haddad, P., Heald, A., Holt, R., Lingford-Hughes, A., Osborn, D., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116645254 · Cited by 292
Metadata
- Authors
- Maayan, L., & Correll, C. U.
- Venue
- Journal of Child and Adolescent Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2011-12
- Volume
- 21
- Issue
- 6
- Pages
- 517-535
- ISSN
- 1044-5463 (ISSN-L)
- 1557-8992
- OpenAlex
- W2041413669
- Cited by
- 252
- References
- 106
- FWCI
- 13.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.liebertpub.com/nv/resources-tools/text-and-data-mining-policy/121/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.